Blood test to predict spread of digestive cancers
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study uses a blood test to look for cancer DNA to predict whether stomach, colon, or pancreatic cancer might spread inside the belly before surgery. Early detection of this risk could help doctors plan better treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stomach, colon, or pancreatic cancer confirmed by biopsy, with a tumor of certain size or with lymph node involvement
- Your cancer has not spread to distant organs based on your initial imaging scans
- You are a candidate for surgery with the goal of removing all cancer
- You are 18 years or older
- You can attend follow-up medical appointments as required by the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a blood-based test to detect unique molecules (called miRNAs) that may signal the presence of several types of gut or digestive system cancers. The goal is to develop a simple screening tool that could catch these cancers earlier.
This study looks at how certain substances in your blood and bacteria in your gut might help predict pancreatic cancer, especially in people with chronic pancreatitis. It aims to find early warning signs to catch cancer sooner.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
This research study uses a blood test to look for signs of colorectal cancer in people who have other types of cancer or digestive diseases. The goal is to see if the test can correctly tell the difference between colorectal cancer and other conditions.
This trial tests a new blood test that may find early signs of cancer in people who have no symptoms. If you join, you'll have a blood draw, and the study will check if the test can catch cancer early.
This study checks whether a blood liquid biopsy test can detect when stomach cancer has spread to the lining of the abdomen (peritoneal metastasis). It compares people with confirmed belly spread to people whose belly lining tests were negative, using blood samples before/around treatment decisions.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.